Keryx Biopharmaceuticals, Inc. Net Profit Margin 2010-2018 | KERX
Keryx Biopharmaceuticals, Inc. net profit margin from 2010 to 2018. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2018-09-30 | $0.10B | $-0.09B | -95.79% |
| 2018-06-30 | $0.08B | $-0.10B | -118.29% |
| 2018-03-31 | $0.07B | $-0.16B | -226.76% |
| 2017-12-31 | $0.06B | $-0.16B | -265.57% |
| 2017-09-30 | $0.05B | $-0.17B | -319.23% |
| 2017-06-30 | $0.04B | $-0.19B | -430.23% |
| 2017-03-31 | $0.04B | $-0.14B | -389.19% |
| 2016-12-31 | $0.03B | $-0.16B | -506.25% |
| 2016-09-30 | $0.03B | $-0.17B | -592.86% |
| 2016-06-30 | $0.03B | $-0.16B | -596.15% |
| 2016-03-31 | $0.02B | $-0.14B | -685.00% |
| 2015-12-31 | $0.01B | $-0.12B | -885.71% |
| 2015-09-30 | $0.01B | $-0.13B | -1400.00% |
| 2015-06-30 | $0.01B | $-0.13B | -2600.00% |
| 2014-12-31 | $0.01B | $-0.11B | -1009.09% |
| 2009-12-31 | $0.03B | $0.01B | 40.00% |
